118 related articles for article (PubMed ID: 10918110)
1. Glyburide-ciprofloxacin interaction with resistant hypoglycemia.
Roberge RJ; Kaplan R; Frank R; Fore C
Ann Emerg Med; 2000 Aug; 36(2):160-163. PubMed ID: 10918110
[TBL] [Abstract][Full Text] [Related]
2. Refractory hypoglycemia from ciprofloxacin and glyburide interaction.
Lin G; Hays DP; Spillane L
J Toxicol Clin Toxicol; 2004; 42(3):295-7. PubMed ID: 15362597
[TBL] [Abstract][Full Text] [Related]
3. Comment on "refractory hypoglycemia from ciprofloxacin and glyburide interaction".
Roberge R
Clin Toxicol (Phila); 2005; 43(3):213-4. PubMed ID: 15902799
[No Abstract] [Full Text] [Related]
4. Hypoglycemia after antimicrobial drug prescription for older patients using sulfonylureas.
Parekh TM; Raji M; Lin YL; Tan A; Kuo YF; Goodwin JS
JAMA Intern Med; 2014 Oct; 174(10):1605-12. PubMed ID: 25179404
[TBL] [Abstract][Full Text] [Related]
5. Coadministration of co-trimoxazole with sulfonylureas: hypoglycemia events and pattern of use.
Tan A; Holmes HM; Kuo YF; Raji MA; Goodwin JS
J Gerontol A Biol Sci Med Sci; 2015 Feb; 70(2):247-54. PubMed ID: 24858839
[TBL] [Abstract][Full Text] [Related]
6. Quinolone-induced hypoglycemia: a life-threatening but potentially reversible side effect.
Kelesidis T; Canseco E
Am J Med; 2010 Feb; 123(2):e5-6. PubMed ID: 20103009
[No Abstract] [Full Text] [Related]
7. A prospective trial of risk factors for sulfonylurea-induced hypoglycemia in type 2 diabetes mellitus.
Burge MR; Schmitz-Fiorentino K; Fischette C; Qualls CR; Schade DS
JAMA; 1998 Jan; 279(2):137-43. PubMed ID: 9440664
[TBL] [Abstract][Full Text] [Related]
8. Octreotide therapy for recurrent refractory hypoglycemia due to sulfonylurea in diabetes-related kidney failure.
Gonzalez RR; Zweig S; Rao J; Block R; Greene LW
Endocr Pract; 2007; 13(4):417-23. PubMed ID: 17669721
[TBL] [Abstract][Full Text] [Related]
9. Severe and persistent hypoglycemia due to gatifloxacin interaction with oral hypoglycemic agents.
Menzies DJ; Dorsainvil PA; Cunha BA; Johnson DH
Am J Med; 2002 Aug; 113(3):232-4. PubMed ID: 12208383
[No Abstract] [Full Text] [Related]
10. The Hypoglycemic Risk of Glyburide (Glibenclamide) Compared with Modified-Release Gliclazide.
Clemens KK; McArthur E; Dixon SN; Fleet JL; Hramiak I; Garg AX
Can J Diabetes; 2015 Aug; 39(4):308-16. PubMed ID: 25840942
[TBL] [Abstract][Full Text] [Related]
11. Semi-mechanistic physiologically-based pharmacokinetic modeling of clinical glibenclamide pharmacokinetics and drug-drug-interactions.
Greupink R; Schreurs M; Benne MS; Huisman MT; Russel FG
Eur J Pharm Sci; 2013 Aug; 49(5):819-28. PubMed ID: 23806476
[TBL] [Abstract][Full Text] [Related]
12. Hypoglycemia caused by maprotiline in a patient taking oral antidiabetics.
Zogno MG; Tolfo L; Draghi E
Ann Pharmacother; 1994 Mar; 28(3):406. PubMed ID: 8193439
[No Abstract] [Full Text] [Related]
13. Anti-infectives and the risk of severe hypoglycemia in users of glipizide or glyburide.
Schelleman H; Bilker WB; Brensinger CM; Wan F; Hennessy S
Clin Pharmacol Ther; 2010 Aug; 88(2):214-22. PubMed ID: 20592722
[TBL] [Abstract][Full Text] [Related]
14. [Diabetes treatment in patients with chronic kidney disease].
Süfke S; Steinhoff J; Schütt M
Dtsch Med Wochenschr; 2013 May; 138(21):1109-18; quiz 1119-22. PubMed ID: 23677506
[No Abstract] [Full Text] [Related]
15. Octreotide: an antidote for sulfonylurea-induced hypoglycemia.
McLaughlin SA; Crandall CS; McKinney PE
Ann Emerg Med; 2000 Aug; 36(2):133-138. PubMed ID: 10918104
[TBL] [Abstract][Full Text] [Related]
16. Severe and resistant hypoglycemia associated with concomitant gatifloxacin and glyburide therapy.
LeBlanc M; Bélanger C; Cossette P
Pharmacotherapy; 2004 Jul; 24(7):926-31. PubMed ID: 15303456
[TBL] [Abstract][Full Text] [Related]
17. Glyburide: a second-generation sulfonylurea hypoglycemic agent. History, chemistry, metabolism, pharmacokinetics, clinical use and adverse effects.
Feldman JM
Pharmacotherapy; 1985; 5(2):43-62. PubMed ID: 3923453
[TBL] [Abstract][Full Text] [Related]
18. Maximal dose glyburide therapy in markedly symptomatic patients with type 2 diabetes: a new use for an old friend.
Peters AL; Davidson MB
J Clin Endocrinol Metab; 1996 Jul; 81(7):2423-7. PubMed ID: 8675555
[TBL] [Abstract][Full Text] [Related]
19. Ibuprofen-related hypoglycemia in a patient receiving sulfonylurea.
Sone H; Takahashi A; Yamada N
Ann Intern Med; 2001 Feb; 134(4):344. PubMed ID: 11182854
[No Abstract] [Full Text] [Related]
20. Evaluation of pharmacokinetic and pharmacodynamic interaction between the dipeptidyl peptidase IV inhibitor vildagliptin, glyburide and pioglitazone in patients with Type 2 diabetes.
Serra D; He YL; Bullock J; Riviere GJ; Balez S; Schwartz S; Wang Y; Ligueros-Saylan M; Jarugula V; Dole WP
Int J Clin Pharmacol Ther; 2008 Jul; 46(7):349-64. PubMed ID: 18793589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
